We are live on ! Find out more
MTFBW

Motif Bio plc Warrants to Purchase ADRs
MTFBW

Delisted

MTFBW was delisted on the 16th of December, 2019.

Back to rankings

3 hedge funds and large institutions have $1.25M invested in Motif Bio plc Warrants to Purchase ADRs in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

4% less capital invested

Capital invested by funds: $1.29M → $1.25M (-$46K)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.56K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$527K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
1
Invesco
Georgia
$987K – – –
SM
2
Sabby Management
Florida
$256K -$527K -270,038 -66%
UBS Group
3
UBS Group
Switzerland
$5K +$1.56K +800 +36%

MTFBW Hedge Fund Activity: Q2 2017 in Review

3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q2 2017, worth a combined $1.25M — down 3.6% from $1.29M a quarter earlier.

Fund positioning in MTFBW was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $1.56K. The largest seller was Sabby Management, cutting an estimated $527K.

  • 3 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $1.25M of Motif Bio plc Warrants to Purchase ADRs stock for Q2 2017, down 3.6% quarter-over-quarter.
  • 0 funds opened new Motif Bio plc Warrants to Purchase ADRs positions in Q2 2017 and 0 closed out.
  • The largest Motif Bio plc Warrants to Purchase ADRs buyer in Q2 2017 was UBS Group, an estimated $1.56K added.
  • The largest Motif Bio plc Warrants to Purchase ADRs seller in Q2 2017 was Sabby Management, an estimated $527K sold.

Based on aggregated 13F filings for Q2 2017.